JP2007500707A5 - - Google Patents

Download PDF

Info

Publication number
JP2007500707A5
JP2007500707A5 JP2006522027A JP2006522027A JP2007500707A5 JP 2007500707 A5 JP2007500707 A5 JP 2007500707A5 JP 2006522027 A JP2006522027 A JP 2006522027A JP 2006522027 A JP2006522027 A JP 2006522027A JP 2007500707 A5 JP2007500707 A5 JP 2007500707A5
Authority
JP
Japan
Prior art keywords
alkyl
formula
compound according
pharmaceutically acceptable
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006522027A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007500707A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/024334 external-priority patent/WO2005012270A2/en
Publication of JP2007500707A publication Critical patent/JP2007500707A/ja
Publication of JP2007500707A5 publication Critical patent/JP2007500707A5/ja
Pending legal-status Critical Current

Links

JP2006522027A 2003-07-29 2004-07-28 ビアリールヘテロ環状のアミン、アミドおよび硫黄−含有化合物、並びに該化合物の製造方法および使用方法 Pending JP2007500707A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49085503P 2003-07-29 2003-07-29
PCT/US2004/024334 WO2005012270A2 (en) 2003-07-29 2004-07-28 Biaryl heterocyclic amines, amides, and sulfur-containing compounds and methods of making and using the same

Publications (2)

Publication Number Publication Date
JP2007500707A JP2007500707A (ja) 2007-01-18
JP2007500707A5 true JP2007500707A5 (https=) 2007-09-06

Family

ID=34115440

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006522027A Pending JP2007500707A (ja) 2003-07-29 2004-07-28 ビアリールヘテロ環状のアミン、アミドおよび硫黄−含有化合物、並びに該化合物の製造方法および使用方法

Country Status (4)

Country Link
US (1) US20070197541A1 (https=)
EP (1) EP1664001A2 (https=)
JP (1) JP2007500707A (https=)
WO (1) WO2005012270A2 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5043428B2 (ja) 2003-06-03 2012-10-10 リブ−エックス ファーマシューティカルズ，インコーポレイテッド ビアリール複素環式化合物ならびにその製造および使用方法
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
EP1660465B1 (en) * 2003-07-29 2014-12-17 Melinta Therapeutics, Inc. Process for the synthesis of biaryl oxazolidinones
JP4777246B2 (ja) * 2003-07-29 2011-09-21 リブ−エックス ファーマシューティカルズ，インコーポレイテッド ビアリールオキサゾリジノンの合成方法
AR046782A1 (es) 2003-12-17 2005-12-21 Rib X Pharmaceuticals Inc Compuestos heterociclicos de biarilo halogenados, composiciones farmaceuticas que los contienen, metodos para su elaboracion y su uso como medicamentos.
US7790754B2 (en) * 2003-12-22 2010-09-07 Merck Sharp & Dohme Corp. Alpha-hydroxy amides as bradykinin antagonists or inverse agonists
DE602006019870D1 (de) 2005-06-08 2011-03-10 Rib X Pharmaceuticals Inc Verfahren zur synthese von triazolen
EP2054383A2 (en) * 2006-08-09 2009-05-06 SmithKline Beecham Corporation Novel compounds as antagonists or inverse agonists at opioid receptors
CN103896796B (zh) 2009-05-28 2016-04-27 诺华股份有限公司 作为脑啡肽酶抑制剂的取代的氨基丙酸衍生物
EP2435402B1 (en) 2009-05-28 2016-04-13 Novartis AG Substituted aminobutyric derivatives as neprilysin inhibitors
JP5640983B2 (ja) * 2009-09-16 2014-12-17 アステラス製薬株式会社 グリシン化合物
JO2967B1 (en) 2009-11-20 2016-03-15 نوفارتس ايه جي Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
US9102635B2 (en) 2013-02-14 2015-08-11 Novartis Ag Substituted bisphenyl butanoic acid derivatives as NEP inhibitors with improved in vivo efficacy
CU24330B1 (es) 2013-02-14 2018-03-13 Novartis Ag Derivados del ácido 4-((1,1) bifenil-4-il)-3-(3-fosfonopropanamido) butanoico, activos como inhibidores de nep (endopeptidasa neutral)
CA2904387C (en) 2013-03-15 2021-12-07 Melinta Therapeutics, Inc. Methods of treating infections in overweight and obese patients using antibiotics
WO2014207708A2 (en) 2013-06-28 2014-12-31 Auckland Uniservices Limited Amino acid and peptide conjugates and conjugation process
WO2016061772A1 (en) 2014-10-22 2016-04-28 Merck Sharp & Dohme Corp. Nargenicin compounds and uses thereof as antibacterial agents
HK1244211A1 (zh) 2014-11-14 2018-08-03 Melinta Therapeutics, Inc. 治疗、预防或降低皮肤感染风险的方法
BR112017013574A2 (pt) 2014-12-23 2018-03-06 Verdon Daniel conjugados de aminoácido e peptídeo e usos dos mesmos
KR20180011843A (ko) 2015-06-11 2018-02-02 바실리어 파마슈티카 인터내셔널 리미티드 유출-펌프 억제제 및 이의 치료적 용도
EP3419962A4 (en) 2016-02-26 2020-03-11 Auckland Uniservices Limited CONJUGATES OF AMINO ACIDS AND PEPTIDES AND CONJUGATION METHOD
CA3045887A1 (en) 2016-12-09 2018-06-14 Celtaxsys, Inc. Pendant amines and derivatives as inhibitors of leukotriene a4 hydrolase
AU2023206316A1 (en) 2022-01-14 2024-08-29 Enko Chem, Inc. Protoporphyrinogen oxidase inhibitors
CN120794967A (zh) * 2024-04-10 2025-10-17 沈阳药科大学 联芳基噁唑烷酮类化合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
DE4425612A1 (de) * 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
TW572757B (en) * 1998-08-24 2004-01-21 Bristol Myers Squibb Co Novel isoxazolinone antibacterial agents
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
BR0111280A (pt) * 2000-06-05 2003-06-10 Dong A Pharm Co Ltd Novos derivados de oxazolidinona e um processo para a preparação dos mesmos
JP5043428B2 (ja) * 2003-06-03 2012-10-10 リブ−エックス ファーマシューティカルズ，インコーポレイテッド ビアリール複素環式化合物ならびにその製造および使用方法
JP4777246B2 (ja) * 2003-07-29 2011-09-21 リブ−エックス ファーマシューティカルズ，インコーポレイテッド ビアリールオキサゾリジノンの合成方法
EP1660465B1 (en) * 2003-07-29 2014-12-17 Melinta Therapeutics, Inc. Process for the synthesis of biaryl oxazolidinones

Similar Documents

Publication Publication Date Title
JP2007500707A5 (https=)
JP2007514782A5 (https=)
JP2013508297A5 (https=)
RU2005100516A (ru) Производные 2-уреидо-6-гетероарил-3н-бензимидазол-6-карбоновой кислоты и родственные соединения в качестве ингибиторов гиразы и/или топоизомеразы iv для лечения бактериальных инфекций
JP2013508299A5 (https=)
CA2513463A1 (en) Gyrase inhibitors and uses thereof
JP2013508298A5 (https=)
PE20120626A1 (es) Composiciones farmaceuticas que comprende nilotinib
JP2004502752A5 (https=)
JP2005533061A5 (https=)
RU2009135067A (ru) Производные иминопиридина и их применение в качестве микробиоцидов
RU2008125055A (ru) 2-(фенил или гетероцикло)-1h-фенантро[9.10-d]имидазолы в качестве ингибиторов mpges-1
CA2433197A1 (en) Gyrase inhibitors and uses thereof
CA2631880A1 (en) Chromane substituted benzimidazoles and their use as acid pump inhibitors
JP2012522053A5 (https=)
JP2003516404A5 (https=)
JP2009514894A5 (https=)
JP2008526999A5 (https=)
DE60115465D1 (de) Immunoregulierende verbindungen, deren derivate und ihre verwendung
KR20060113625A (ko) 시클로프로필기 치환된 옥사졸리디논 항생제 및 그의유도체
ES2408597T3 (es) 1,2,3-triazoles inhibidores de la polimerización de la tubulina para el tratamiento de trastornos proliferativos
JP2014513690A5 (https=)
JP2003518106A5 (https=)
RU2006100484A (ru) Соединения, обладающие ингибирующей активностью в отношении фосфатидилинозит-3-киназы, фармацевтическая композиция, способ определения эффективности этих соединений, способ лечения нарушений (варианты) и способ изменения передачи сигнала в клетках
JP2020519687A5 (https=)